Adrenal
2 trials- 2020LINC-3Cushing's diseaseIn 137 adults with Cushing's disease, osilodrostat achieved control of mean 24-h urinary free cortisol in a randomised-withdrawal phase versus placebo.
- 2016SPARTACUSPrimary aldosteronism subtypingIn 200 patients with primary aldosteronism, CT-based subtyping did not differ from adrenal-vein-sampling-based subtyping for antihypertensive intensity at 1 year.